Source: Park, Kyoung-Ha, and Woo Jung Park
466-468 Secondary Prevention: Foundational Evidence In a randomized placebo-controlled trial, 5,522 patients with chronic coronary artery disease (about 84% of whom had already experienced a major coronary event) receiving standard cardiovascular risk-lowering therapies were given 0.5 mg of colchicine or placebo daily
Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial
How Telehealth Can Help Accessing expert advice quickly is easier than ever with telehealth platforms like Doctronic.ai
For noise, consistent low-frequency sound (white noise, fan) is superior to silence in most urban and suburban environments because it masks intermittent disruptions (traffic, pets, partners) that fragment sleep without fully waking you